Study concept and design: Kiss, Brambilla, Glynn, Mast, Spencer, Kleinman, Cable.
Acquisition, analysis, or interpretation of data: Kiss, Brambilla, Glynn, Mast, Spencer, Stone, Cable.
Drafting of the manuscript: Kiss, Brambilla, Glynn, Stone, Cable.
Critical revision of the manuscript for important intellectual content: Kiss, Brambilla, Glynn, Mast, Spencer, Stone, Kleinman, Cable.
Statistical analysis: Kiss, Brambilla, Glynn, Spencer.
Obtained funding: Kiss, Brambilla, Mast, Cable.
Administrative, technical, or material support: Spencer, Stone, Cable.
Study supervision: Kiss, Mast, Stone, Cable.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mast reported having received a grant from Novo Nordisk and honoraria from Siemens. No other disclosures were reported.
Funding/Support: This work was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201100001I, HHSN268201100002I, HHSN268201100003I, HHSN268201100004I, HHSN268201100005I, and HHSN268201100006I.
Role of the Funder/Sponsor: The study sponsor, NHLBI, participated in the design, approval, and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication.
Group Members: The NHLBI Recipient Epidemiology Donor Evaluation Study–III (REDS-III), domestic component, is the responsibility of the following persons: Hubs: A. E. Mast and J. L. Gottschall, BloodCenter of Wisconsin, Milwaukee; D. J. Triulzi and J. E. Kiss, Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; E. L. Murphy and E. W. Fiebig, University of California, San Francisco; E. L. Snyder, Yale University School of Medicine, New Haven, Connecticut; R. G. Cable, American Red Cross Blood Services, Farmington, Connecticut. Data coordinating center: D. J. Brambilla and M. T. Sullivan, RTI International, Rockville, Maryland. Central laboratory: M. P. Busch and P. J. Norris, Blood Systems Research Institute, San Francisco. Publication committee chairman: R. Y. Dodd, American Red Cross, Holland Laboratory, Rockville. Steering committee chairman: S. H. Kleinman, University of British Columbia, Victoria, Canada. National Heart, Lung, and Blood Institute, National Institutes of Health: S. A. Glynn and A. M. Cristman.
Additional Contributions: We wish to recognize the special expertise of our friend and colleague, Leslie H. Tobler, DrPH (deceased), of Blood Systems Research Institute, San Francisco, California, who coordinated the Central Laboratory and assisted with the design and analysis of this study. We thank the safety medical monitor for the study, Ann Zimrin, MD, of the University of Maryland, and the research staff responsible for donor enrollment, follow-up, and data collection at the 4 REDS-III hubs (Walt Bialkowski, MS; Shanita Thomas, BS; Zoya Udee, BA; Pam D’Andrea, RN; Barb Kletter, CMA; Chris Sayre, BS, MT, ASCP, MBA; Anne Guiltinan, MA, LMFT; Daniel A. Hindes, BA; Monalissa Doane, MS), the staff responsible for protocol and data management at the coordinating center (Christopher Siege, BS, MS; Anne-Lyne McCalla, BS, MPH), and the staff responsible for laboratory testing and data management at the central laboratory (BSRI Viral Reference Laboratory and Repository Core) for their commitment to the study and skillful support. All staff received contractual financial support.